Indegene and Datavant Partnership Analyzed
Indegene, a company that helps drug companies find patients for research, has teamed up with Datavant. This partnership aims to make it much easier and faster to find people who can participate in medical studies. Specifically, they’re focusing on difficult-to-study conditions like rare diseases.
Key Points
- Indegene & Datavant partner to speed clinical trial recruitment.
- Focus on rare diseases and complex medical research studies.
- Real-time patient data access improves trial participant matching.
- Faster enrollment reduces ‘screen failures’ in clinical trials.
- Data-driven approaches lead to better trial outcomes quickly.
- Partnership boosts efficiency for drug and biotech companies.
Datavant has a huge network of hospitals and clinics – it gathers information from over 80,000 locations and handles over 100 million patient records every year. This gives Indegene a powerful tool to find the right patients for research.
A big problem in medical research is that it’s hard to find enough people who meet the requirements for a study. Often, patients with rare diseases are spread out and hard to locate. This partnership solves this problem by providing access to detailed patient information quickly.
Indegene’s goal is to help drug and biotech companies get their products to market faster and more effectively. They do this by streamlining the process of finding patients for clinical trials. The partnership with Datavant is a crucial part of this strategy.
The results of this collaboration will lead to more clinical trials having enough participants, leading to quicker advancements in medicine and better treatments for patients.
“We are doubling down on enhancing our capabilities to deliver digital-first recruitment solutions for clients to transform clinical trial execution.” – Ram Yeleswarapu, SVP, Enterprise Clinical Solutions at Indegene.
Indegene’s financial performance has also been strong, with a significant increase in revenue and profits. This successful partnership underscores their commitment to innovation and growth within the life sciences sector.
